ClinicalTrials.gg
RecruitingNCT06370325Updated Feb 27, 2026

Neuromuscular Electrical Stimulation in Foot and Ankle Surgery

An interventional study of VPOD Wireless Tens Unit and Physical Therapy in Ankle Fractures, sponsored by NYU Langone Health. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 60 studies in Ankle Fractures with a site in United States — 16 open to participants now, 20 under way, none of them phase 3. Ankle Fractures · United States.

Planned enrollment
37th of 49
20 · median 55
Started
2025
with 4 others
No phase
37 of 60
13 open now
Primary completion
2026-12
later than 5 of 19 live
Registered
54th of 60
by date
Lead sponsor
3 of 60
NYU Langone Health

Among the 60 studies in Ankle Fractures with a site in United States, this one is the 37th largest by planned enrollment of the 49 interventional ones that give a count, is one of 5 that started in 2025, is one of 37 with no phase, reaches primary completion later than 5 of the 19 other live ones, and was the 54th registered.

Ankle Fractures

203 studies on the registry are indexed under Ankle Fractures; 45 are open to participants now.

Browse Ankle Fractures studies →

Open to participants now

16 of the 60 studies in Ankle Fractures with a site in United States are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 31 Ankle Fractures studies recruiting now, 14 (45%) set no upper age limit and 12 (39%) stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Ankle Fractures with a site in United States, or all of them as a file.
02

Study summary

This is a pilot randomized controlled trial, wherein the intervention group will undergo NMES five days a week beginning three weeks postoperative and lasting for ten weeks. Both the control and intervention groups will start standard physical therapy six weeks postoperative. Primary outcome measure will be the isometric strength of the gastrocnemius muscle. The secondary outcomes will comprise subjective clinical evaluations (using the Lower Extremity Functional Scale [LEFS]), functional assessments such as the sit-to-stand test, 2-minute walk test, stair climb test and objective clinical evaluation using contralateral comparison of calf circumference.

03

Conditions studied

  • Ankle Fractures

Browse trials for

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Capable and willing to provide
  • Undergoing a procedure that involves repairing an ankle fracture.

Exclusion criteria

Exclusion Criteria:

Patients with medical histories that include:

  • Rheumatoid arthritis
  • Connective tissue disorders
  • Chronic use
  • Implanted electrical devices
  • Neurological disorders
  • Non-ambulatory status
  • Recent surgery (within the last 3 months) that is not related to the study
  • Scheduled to undergo surgery in the near future
  • Epilepsy
  • Diagnosed with cancer
  • Have suffered acute trauma or recently have had a surgical procedure (not related to the study)
  • Have cardiac problems or cardiac disease
  • Have an abdominal hernia
  • Have venous thrombosis
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Participants randomized to the intervention group will undergo neuromuscular electrical stimulation (NMES) five days a week beginning three weeks postoperative and lasting for ten weeks. The intervention group will begin standard physical therapy at six weeks postoperative.

    Procedure: VPOD Wireless Tens Unit · Procedure: Physical Therapy · Device: Biodex

  • Active comparator
    Control Group

    Participants randomized to the control group will begin standard physical therapy at six weeks postoperative.

    Procedure: Physical Therapy · Device: Biodex

Interventions

  • ProcedureVPOD Wireless Tens Unit

    The VPOD unit will deliver NMES to participants in the Intervention Group.

  • ProcedurePhysical Therapy

    Physical therapy as per standard of care.

  • DeviceBiodex

    Used to assess strength, endurance, power, and range of motion.

06

What researchers measure

Primary outcomes

  1. Isometric Strength of Gastrocnemius Muscle

    Measured using Biodex dynamometer.

    Time frame: Week 6

  2. Isometric Strength of Gastrocnemius Muscle

    Measured using Biodex dynamometer.

    Time frame: Week 9

  3. Isometric Strength of Gastrocnemius Muscle

    Measured using Biodex dynamometer.

    Time frame: Week 12

  4. Bilateral Calf Circumference

    Time frame: Week 6

  5. Bilateral Calf Circumference

    Time frame: Week 9

  6. Bilateral Calf Circumference

    Time frame: Week 12

Secondary outcomes

  1. Lower Extremity Functional Scale (LEFS) Questionnaire Score

    LEFS is a 20-item questionnaire assessing functional impairment in patients with disorders affecting one or both lower extremities. Each item is rated on a scale ranging from 0 to 4: 0 indicates inability to perform the activity or extreme difficulty, 1 indicates considerable difficulty, 2 indicates moderate difficulty, 3 indicates slight difficulty, and 4 indicates no difficulty. The score is the sum of responses and ranges from a minimum of 0 to a maximum of 80, with lower scores indicating greater disability.

    Time frame: Week 6

  2. Lower Extremity Functional Scale (LEFS) Questionnaire Score

    LEFS is a 20-item questionnaire assessing functional impairment in patients with disorders affecting one or both lower extremities. Each item is rated on a scale ranging from 0 to 4: 0 indicates inability to perform the activity or extreme difficulty, 1 indicates considerable difficulty, 2 indicates moderate difficulty, 3 indicates slight difficulty, and 4 indicates no difficulty. The score is the sum of responses and ranges from a minimum of 0 to a maximum of 80, with lower scores indicating greater disability.

    Time frame: Week 9

  3. Lower Extremity Functional Scale (LEFS) Questionnaire Score

    LEFS is a 20-item questionnaire assessing functional impairment in patients with disorders affecting one or both lower extremities. Each item is rated on a scale ranging from 0 to 4: 0 indicates inability to perform the activity or extreme difficulty, 1 indicates considerable difficulty, 2 indicates moderate difficulty, 3 indicates slight difficulty, and 4 indicates no difficulty. The score is the sum of responses and ranges from a minimum of 0 to a maximum of 80, with lower scores indicating greater disability.

    Time frame: Week 12

  4. Sit-to-Stand Test

    The sit-to-stand test involves recording the number of stands a person can complete in 30 seconds.

    Time frame: Week 6

  5. Sit-to-Stand Test

    The sit-to-stand test involves recording the number of stands a person can complete in 30 seconds.

    Time frame: Week 9

  6. Sit-to-Stand Test

    The sit-to-stand test involves recording the number of stands a person can complete in 30 seconds.

    Time frame: Week 12

  7. 2 Minute Walk Test

    In this activity, the participant is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured

    Time frame: Week 6

  8. 2 Minute Walk Test

    In this activity, the participant is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured

    Time frame: Week 9

  9. 2 Minute Walk Test

    In this activity, the participant is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured

    Time frame: Week 12

  10. Stair Climb Test

    The stair climb test measures the amount of time a person ascends and descends a flight of stairs, while walking as quickly as they feel safe and comfortable to move.

    Time frame: Week 6

  11. Stair Climb Test

    The stair climb test measures the amount of time a person ascends and descends a flight of stairs, while walking as quickly as they feel safe and comfortable to move.

    Time frame: Week 9

  12. Stair Climb Test

    The stair climb test measures the amount of time a person ascends and descends a flight of stairs, while walking as quickly as they feel safe and comfortable to move.

    Time frame: Week 12

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Data to be used only by the research team.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Dec 2026, 18 months after the start.

Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 18 months is below that.

Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 12, 2024
First posted
Apr 17, 2024
StartActual
Jun 19, 2025
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Feb 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06370325
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Apr 17, 2024
Start date
Jun 19, 2025
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Feb 27, 2026

Study contacts

Raymond J. Walls, MD
Contact
Raymond.Walls@nyulangone.org
(917) 780-8720
Thelma Jimenez Mosquea, MD
Contact
Thelma.JimenezMosquea@nyulangone.org
(347) 880-2254
Raymond J. Walls, MD
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion